Cleared Traditional

K012072 - VOXAR VC, MODEL 1.0

K012072 is an FDA 510(k) clearance for VOXAR VC, manufactured by Voxar Limited. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 10-day FDA review.

K012072 · Voxar Limited · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2001
Decision
10d
Days
Class 2
Risk

K012072 is an FDA 510(k) clearance for the VOXAR VC, MODEL 1.0. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Voxar Limited (Edinburgh, Lothian, GB). The FDA issued a Cleared decision on July 12, 2001 after a review of 10 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

FDA 510(k) Submission Details - K012072

510(k) Number K012072 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 02, 2001
Decision Date July 12, 2001
Days to Decision 10 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Statement
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
97d faster than avg
Panel avg: 107d · This submission: 10d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Underwriters Laboratories, Inc.
R. KENT DONOHUE

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 2285
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K012072.
QCU ANALYTICAL SOFTWARE PACKAGE
K011582 · Medis Medical Imaging Systems BV · Jul 2001
MONOCHROME PERFECTLY FLAT PANEL DISPLAYS, ME SERIES
K012099 · Totoku Electric Co., Ltd. · Jul 2001
EFILM WORKSTATION
K012211 · Efilm Medical, Inc. · Jul 2001
VORTEX
K012097 · Ultravisual Medical Systems · Jul 2001
TELEPAX
K011173 · Imed Systems & Consulting, LLC · Jul 2001
SYNGO MULTIMODALITY WORKSTATION
K010938 · Siemens Medical Solutions USA, Inc. · Jun 2001
K012072 · VOXAR VC, MODEL 1.0
Download PDF Voxar Limited